Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 13
Original Research
Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,942 | Dovepress* | 10,831+ | 1,720 | 12,551 | |
| PubMed Central* | 1,111 | 407 | 1,518 | ||
| Totals | 11,942 | 2,127 | 14,069 | ||
| *Since 29 June 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 0 | 4 |
View citations on PubMed Central and Google Scholar